SIMCERE PHARMAC (Germany) Price Prediction

Intrinsic Valuation Low Real High 0.04 0.81 3.87 Details

SIMCERE PHARMAC After-Hype Price Prediction Density Analysis

SIMCERE PHARMAC Estimiated After-Hype Price Volatility

SIMCERE PHARMAC Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.23	3.06	0.00	0.00	0 Events / Month	0 Events / Month	Within a week

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.81	0.81	0.00	0.00   Notes

SIMCERE PHARMAC Hype Timeline

SIMCERE PHARMAC GRP is at this time traded for 0.81on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SIMCERE is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.23%. %. The volatility of related hype on SIMCERE PHARMAC is about 0.0%, with the expected price after the next announcement by competition of 0.81. About 69.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 28th of June 2022. Assuming the 90 days horizon the next estimated press release will be within a week. Check out SIMCERE PHARMAC Basic Forecasting Models to cross-verify your projections.

SIMCERE PHARMAC Related Hype Analysis

SIMCERE PHARMAC Additional Predictive Modules

Most predictive techniques to examine SIMCERE price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SIMCERE using various technical indicators. When you analyze SIMCERE charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of SIMCERE PHARMAC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SIMCERE PHARMAC GRP, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SIMCERE PHARMAC based on analysis of SIMCERE PHARMAC hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for SIMCERE PHARMAC depends on current market conditions and SIMCERE PHARMAC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SIMCERE PHARMAC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SIMCERE PHARMAC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

SIMCERE PHARMAC's future price predictability will typically decrease when SIMCERE PHARMAC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of SIMCERE PHARMAC GRP often depends not only on the future outlook of the potential SIMCERE PHARMAC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SIMCERE PHARMAC's indicators that are reflective of the short sentiment are summarized in the table below.

When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.